PAPER Amber S, Sumera, Mirza FJ, Asif M, Hassan D, Ahmed T, Zahid S
SEARCH RESULTS
4516 RESULTS
PAPER Weller A, Bischof GN, Schlüter P, Richter N, Dronse J, Onur O, Neumaier B, Kukolja J, Langen KJ, Fink G, Kunoth A, Shao Y, van Eimeren T, Drzezga A
Finding New Communities: A Principle of Neuronal Network Reorganization in Alzheimer's Disease.
Brain Connect. 2021 Apr;11(3):225-238. Epub 2021 Feb 5 PubMed: 33356820PAPER Lin PC, Lin HT, Yang YH, Yang YH
The effects of caregiver characteristics on behavioral and psychological symptoms of dementia of patients with dementia.
Aging Ment Health. 2020 Dec 24;:1-7. PubMed: 33356486PAPER Viayna E, Coquelle N, Cieslikiewicz-Bouet M, Cisternas P, Oliva CA, Sánchez-López E, Ettcheto M, Bartolini M, De Simone A, Ricchini M, Rendina M, Pons M, Firuzi O, Pérez B, Saso L, Andrisano V, Nachon F, Brazzolotto X, García ML, Camins A, Silman I, Jean L, Inestrosa NC, Colletier JP, Renard PY, Muñoz-Torrero D
Discovery of a Potent Dual Inhibitor of Acetylcholinesterase and Butyrylcholinesterase with Antioxidant Activity that Alleviates Alzheimer-like Pathology in Old APP/PS1 Mice.
J Med Chem. 2021 Jan 14;64(1):812-839. Epub 2020 Dec 28 PubMed: 33356266PAPER Abd El-Rady NM, Ahmed A, Abdel-Rady MM, Ismail OI
Glucagon-like peptide-1 analog improves neuronal and behavioral impairment and promotes neuroprotection in a rat model of aluminum-induced dementia.
Physiol Rep. 2021 Jan;8(24):e14651. PubMed: 33355990PAPER Voysey Z, Fazal SV, Lazar AS, Barker RA
The sleep and circadian problems of Huntington's disease: when, why and their importance.
J Neurol. 2021 Jun;268(6):2275-2283. Epub 2020 Dec 23 PubMed: 33355880PAPER Holubová M, Lobaz V, Loukotová L, Rabyk M, Hromádková J, Trhlíková O, Pechrová Z, Groborz O, Štěpánek P, Hrubý M
Chemically modified glycogens: how they influence formation of amyloid fibrils?
Soft Matter. 2021 Feb 19;17(6):1614-1627. PubMed: 33355593PAPER Holubová M, Lobaz V, Loukotová L, Rabyk M, Hromádková J, Trhlíková O, Pechrová Z, Groborz O, Štěpánek P, Hrubý M
Does polysaccharide glycogen behave as a promoter of amyloid fibril formation at physiologically relevant concentrations?
Soft Matter. 2021 Feb 19;17(6):1628-1641. PubMed: 33355589PAPER Roberts G, Donaghy PC, Lloyd J, Durcan R, Petrides G, Colloby SJ, Lawley S, Ciafone J, Hamilton CA, Firbank M, Allan L, Barnett N, Barker S, Olsen K, Howe K, Ali T, Taylor JP, O'Brien J, Thomas AJ
Accuracy of dopaminergic imaging as a biomarker for mild cognitive impairment with Lewy bodies.
Br J Psychiatry. 2020 Dec 23;:1-7. PubMed: 33355065PAPER Pavón S, Lázaro E, Martínez O, Amayra I, López-Paz JF, Caballero P, Al-Rashaida M, Luna PM, García M, Pérez M, Berrocoso S, Rodríguez AA, Pérez-Núñez P
Ketogenic diet and cognition in neurological diseases: a systematic review.
Nutr Rev. 2021 Jun 4;79(7):802-813. PubMed: 33354711PAPER Wakim NI, Braun TM, Kaye JA, Dodge HH, for ORCATECH
Choosing the right time granularity for analysis of digital biomarker trajectories.
Alzheimers Dement (N Y). 2020;6(1):e12094. Epub 2020 Dec 18 PubMed: 33354618PAPER Arca VM, Lucena LO, Barbosa BJ
Letter to the Editor: Relations between subjective well-being and Alzheimer's disease: a systematic review.
Dement Neuropsychol. 2020 Dec;14(4):440-441. PubMed: 33354301PAPER da Silva AC, Ansai JH, Cezar NO, Carvalho Vale FA, Dos Santos JG, de Andrade LP
Outcomes and interventions in the elderly with and without cognitive impairment: a longitudinal study.
Dement Neuropsychol. 2020 Dec;14(4):394-402. PubMed: 33354293PAPER Andrade SK, de Melo MC, de Lima BF, Porto FH, Peixoto VG, Gazzola JM
Loss of functional capacity in elderly individuals with Alzheimer disease.
Dement Neuropsychol. 2020 Dec;14(4):387-393. PubMed: 33354292PAPER Martorelli M, Hartle L, Coutinho G, Mograbi DC, Chaves D, Silberman C, Charchat-Fichman H
Diagnostic accuracy of early cognitive indicators in mild cognitive impairment.
Dement Neuropsychol. 2020 Dec;14(4):358-365. PubMed: 33354288Current Filters
- Date Range : Oct 2020 to Jan 2021 x